Trial · NCT01733212
Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
NCT01733212, Phase 2, Phase 3, Completed, Joel Yarmush; results first posted 2018-05-11
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients. Trials, record NCT01733212. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01733212
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
- NCT number
- NCT01733212
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 239 participants, actual
- Lead sponsor
- Joel Yarmush
- Conditions
- Nausea, Vomiting
- Interventions
- Ginger, Placebo Oral Tablet
- First posted
- 2012-11-26
- Last updated
- 2021-09-10
- Results first posted
- 2018-05-11
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Occurrence of Intra-operative and Post-operative Vomiting | During surgery (1 hour) and thru 72 hours after surgery | Participants who had intra-operative and post-operative vomiting were identified and compared between the two groups. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Occurrence of Intra-operative and Post-operative Vomiting | During surgery (1 hour) and thru 72 hours after surgery | Number of participants who had vomiting in each group is compared to the other group using Chi square test | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Occurrence of Intra-operative and Post-operative Vomiting | Ginger | 30 | Participants | ||
| Occurrence of Intra-operative and Post-operative Vomiting | Placebo | 45 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Ginger | 116 | |
| Overall Study | STARTED | Placebo | 123 | |
| Overall Study | COMPLETED | Ginger | 116 | |
| Overall Study | COMPLETED | Placebo | 123 | |
| Overall Study | NOT COMPLETED | Ginger | 0 | |
| Overall Study | NOT COMPLETED | Placebo | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Ginger | 0 | 116 |
| Total, all-cause mortality | Placebo | 0 | 123 |
| Total, other adverse events | Ginger | 0 | 116 |
| Total, other adverse events | Placebo | 0 | 123 |
| Total, serious adverse events | Ginger | 0 | 116 |
| Total, serious adverse events | Placebo | 0 | 123 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Ginger vs Placebo: Occurrence of Intra-operative and Post-operative Vomiting | Trial comparisons |
| Ginger vs Placebo: deaths from any cause | Trial comparisons |
| Ginger vs Placebo: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01733212
GET https://conductscience.org/api/trials/v1/NCT01733212/registered